Pizzale Stephen, Gollob Michael H, Gow Robert, Birnie David H
University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
J Cardiovasc Electrophysiol. 2008 Dec;19(12):1319-21. doi: 10.1111/j.1540-8167.2008.01211.x. Epub 2008 Jun 12.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial condition that presents with exercise-induced syncope or sudden death in children or young adults. In most cases the disease is caused by a mutation in the cardiac ryanodine receptor (RyR2) gene. Current evidence suggests that primary therapy for CPVT is beta blockade and implantable cardioverter defibrillator (ICD) placement. There is a recent report of a patient with CPVT who died despite appropriate ICD therapies, and we report a similar case. Our patient died after probably initially receiving inappropriate ICD shocks for atrial fibrillation. We recommend that utmost efforts should be made to prevent shocks including repeated exercise testing to confirm suppression of PVT.
儿茶酚胺能性多形性室性心动过速(CPVT)是一种家族性疾病,表现为儿童或年轻人运动诱发的晕厥或猝死。在大多数情况下,该疾病由心脏兰尼碱受体(RyR2)基因突变引起。目前的证据表明,CPVT的主要治疗方法是β受体阻滞剂和植入式心脏复律除颤器(ICD)植入。最近有报道称,一名CPVT患者尽管接受了适当的ICD治疗仍死亡,我们报告了一例类似病例。我们的患者在最初可能因房颤接受了不适当的ICD电击后死亡。我们建议应尽最大努力预防电击,包括反复进行运动测试以确认室性心动过速得到抑制。